Report: Investors Urge Ouster of Regeneron Director Over Executive Compensation

Retrieved on: 2021-06-10 17:12:05

Tags for this article:

Articles

Corporate law

George Yancopoulos

Regeneron Pharmaceuticals

Executive compensation

Leonard Schleifer

Board of directors

United States corporate law

Regeneron

Click the tags to see associated articles and topics

Report: Investors Urge Ouster of Regeneron Director Over Executive Compensation. View article details on HISWAI: https://www.biospace.com/article/investors-urge-ouster-of-regeneron-director-over-executive-compensation-report-says/

Excerpt

... previously granted to the company for REGEN-COV, its antibody cocktail. ... combining two monoclonal antibodies, casirivimab and imedvimab.

Article found on: www.biospace.com

View Original Article